Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 49: 518-520, 2003; 10.1373/49.3.518
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, S.
Right arrow Articles by Collins, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, S.
Right arrow Articles by Collins, R.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2003;49:518-520.)
© 2003 American Association for Clinical Chemistry, Inc.

Technical Briefs

Stabilization of Homocysteine in Unseparated Blood over Several Days: A Solution for Epidemiological Studies

Sarah Clarka1, Linda D. Youngman1, Joan Sullivan1, Richard Peto1 and Rory Collins1

1 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX2 6HE, United Kingdom

aaddress correspondence to this author at: Clinical Trial Service Unit and Epidemiological Studies Unit, Harkness Building, Radcliffe Infirmary, Oxford OX2 6HE, United Kingdom; fax 44-1865-558817, e-mail sarah.clark@ctsu.ox.ac.uk

The first 20% of the full text of this article appears below.

Increased blood homocysteine is a potentially modifiable risk factor for cardiovascular disease. In a recent metaanalysis of individual participant data from prospective epidemiologic studies, a 25% lower homocysteine concentration was associated with an 11% lower risk for ischemic heart disease and a 19% lower risk for stroke (1). Blood homocysteine is easily lowered by folic acid supplementation, and several large-scale randomized trials are currently underway to assess the effects of homocysteine-lowering vitamin supplements on the risk of vascular disease. If such trials demonstrate benefit, there will be increasing interest in homocysteine determinations to assess vascular disease risk. In addition, further large-scale epidemiologic studies may be required to investigate the association between homocysteine and cardiovascular disease in a wider range of populations. These would be facilitated by simple and cost-effective methods for blood collection and analysis.

One of the chief constraints in homocysteine measurements is the continuing production and release of homocysteine by red blood cells after venipuncture, which causes an artificial increase in plasma concentration of ~10% per hour (2)(3). It has been recommended, therefore, that blood samples for homocysteine measurements be drawn into tubes containing EDTA, chilled, or placed on ice immediately after collection and that the plasma be separated from the red cells within 1 h. Such procedures can be difficult to implement in large-scale epidemiologic studies or other situations in which samples have to be collected remotely (e.g., in multiple clinics or in people’s homes) and transported to a central laboratory. Use of NaF . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
R. R. Calam, I. Mansoor, and J. Blaga
Homocysteine Stability in Heparinized Plasma Stored in a Gel Separator Tube
Clin. Chem., August 1, 2005; 51(8): 1554 - 1555.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Scheidhauer, B. Guessregen, A. Hohl, and T. Arndt
Effects of Prolonged Ambient Storage of Sodium Fluoride/Heparin Specimens on Plasma Homocysteine
Clin. Chem., August 1, 2005; 51(8): 1564 - 1565.
[Full Text] [PDF]

Home page
 Obstet GynecolHome page
L. E. Mignini, P. M. Latthe, J. Villar, M. D. Kilby, G. Carroli, and K. S. Khan
Mapping the Theories of Preeclampsia: The Role of Homocysteine
Obstet. Gynecol., February 1, 2005; 105(2): 411 - 425.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. von Eckardstein
Is there a need for novel cardiovascular risk factors?
Nephrol. Dial. Transplant., April 1, 2004; 19(4): 761 - 765.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.